IAMA THERAPEUTICS
At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families with the support they need.
IAMA THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2021-01-01
Website Url:
http://www.iamatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.8 M USD
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.iamatherapeutics.com Semrush global rank: 6.09 M Semrush visits lastest month: 1.33 K
- Host name: 73.245.214.35.bc.googleusercontent.com
- IP address: 35.214.245.73
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Iama Therapeutics"
Iama Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference …See details»
Iama Therapeutics Srl - Drug pipelines, Patents, Clinical trials
Www.iamatherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. ... The statistics for …See details»
Science – IAMA Therapeutics
A signaling imbalance between excitation and inhibition in the brain causes some epilepsies and forms of autism. NKCC1 is a member of the Cation Chloride Cotransporter family, which mediate chloride transport across the membrane.. …See details»
IAMA Therapeutics - LinkedIn
IAMA Therapeutics is a clinical-stage pharmaceutical company raising a Series B to fund the clinical development of its lead candidate in epilepsy and neurodevelopment disorders.See details»
Team – IAMA Therapeutics
IAMA is a team of experienced scientists, researchers, and industry experts motivated by a shared commitment to developing new treatments to make an impact on individuals affected …See details»
IAMA Therapeutics - PitchBook
Mar 29, 2022 IAMA Therapeutics General Information Description. Developer of novel drugs intended to treat brain disorders. The company's drug can significantly alleviate the learning …See details»
IAMA Therapeutics - VentureRadar
At IAMA Therapeutics, a series-A pharmaceutical company, we are constantly pushing the boundaries of neuroscience drug discovery to develop new... ... Find out more ...See details»
Iama Therapeutics | BioPharm America
At IamaTherapeutics, a series-A pharmaceutical company, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference …See details»
IAMA Therapeutics Company Information - Funding, Investors, …
Https://iamatherapeutics.com. IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain. Stay up to date with our weekly …See details»
IAMA Therapeutics Announces Approval of Clinical Trial …
GENOA, Italy, December 20, 2023--IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by …See details»
IAMA Therapeutics Announces Approval of Clinical Trial …
GENOA, Italy, December 20, 2023 — IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by …See details»
IAMA Therapeutics Announces Formation of Scientific Advisory …
Mar 31, 2022 IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to makeSee details»
IAMA Therapeutics - Products, Competitors, Financials, Employees ...
Cava Healthcare. Cava Healthcare is a company focused on enhancing optimal health, operating in the healthcare and biotechnology sectors. The company's main services include the …See details»
IAMA Therapeutics - BIO International Convention | BIO
Jun 7, 2023 IAMA Therapeutics is a Series A- late preclinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel medicines to make a …See details»
IAMA Therapeutics to Present at Upcoming BIO ... - Business Wire
Jun 1, 2023 GENOA, Italy--(BUSINESS WIRE)--IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of …See details»
IAMA Therapeutics Announces Multi-Phase, Strategic Provider …
GENOA, Italy, October 02, 2023 — IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by …See details»
IAMA Therapeutics Announces Multi-Phase, Strategic ... - Business …
Oct 2, 2023 IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by bSee details»
News - IAMA Therapeutics
GENOA, Italy, January 23, 2024 — IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by …See details»
Marco De Vivo - IAMA Therapeutics
He is also Director of the Italian CECAM-IT-SIMUL node of the CECAM (Centre Européen de Calcul Atomique et Moléculaire) organization, which promotes advanced computational …See details»